Incidence and prognostic significance of acute renal failure in myeloablative and non-myeloablative allogeneic stem cell transplant. single center experience

被引：0

作者：

Sitges, Marta ^{[1
]}

Ferra, Christelle ^{[1
]}

Soler, Jordi ^{[2
]}

Morgades, Mireia ^{[1
]}

Jose Jimenez, Maria ^{[1
]}

Hernandez, Ines ^{[1
]}

Torrent, Anna ^{[1
]}

Pena, Marta ^{[1
]}

Gener, Georgina ^{[1
]}

Franch, Mireia ^{[1
]}

Santos, Mireia ^{[1
]}

Canamero, Eloi ^{[1
]}

Comes, Martina ^{[1
]}

Espasa, Andrea ^{[1
]}

Batlle, Montserrat ^{[1
]}

Moreno, Miriam ^{[1
]}

Vives, Susana ^{[1
]}

Manuel Sancho, Juan ^{[1
]}

Xicoy, Blanca ^{[1
]}

Oriol, Albert ^{[1
]}

Abril, Laura ^{[1
]}

Ibarra, Gladys ^{[1
]}

Maria Ribera, Jose ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Inst Catala Oncol, Josep Carreras Res Inst, Hosp Germans Trias & Pujol, Badalona, Spain

[2] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P197

引用

页码：274 / 274

页数：1

共 50 条

[1] Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma - single center experience
Rzepecki, P
Zolnierek, J
Sarosiek, T
Langiewicz, P
Szczylik, C
NEOPLASMA, 2005, 52 (03) : 238 - 242
[2] Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives
Saito, T
Mineishi, S
EXPERIMENTAL ONCOLOGY, 2001, 23 (01): : 4 - 10
[3] Efficacy of performing a second non-myeloablative allogenic stem cell transplant.
Byrne, BJ
Antin, JH
Alyea, EP
Choa, NJ
Rizzieri, DA
BLOOD, 2005, 106 (11) : 1020A - 1020A
[4] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
Schrier, RW
Parikh, CR
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
[5] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
Körbling, M
Khouri, I
HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
[6] Low incidence of infectious complications after non-myeloablative compared with myeloablative allogeneic stem cell transplantation
Meijer, E
Dekker, A
Lokhorst, H
Petersen, E
Nieuwenhuis, K
BONE MARROW TRANSPLANTATION, 2005, 35 : S198 - S198
[7] Incidence of cytomegalovirus infection after allogeneic stem cell transplantation conditioned with myeloablative and non-myeloablative regimens
Irrera, I
Morabito, F
Cuzzola, M
Cuzzocrea, A
Iacopino, O
Penna, G
Console, G
Messina, G
Martino, M
Iacopino, P
BONE MARROW TRANSPLANTATION, 2003, 31 : S97 - S97
[8] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
Yun, Tak
Lee, Keun-Wook
Song, Eun-Gi
Na, Im-Il
Shin, Hyun-Chun
Yoon, Sung-Soo
Park, Seon-Yang
Kim, Byoung-Kook
Lee, Jung-Hee
Choi, Seong-Jun
Lee, Je-Hwan
Lee, Kyoo-Hyung
CLINICAL TRANSPLANTATION, 2007, 21 (03) : 337 - 343
[9] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
Bahnson, R
Hu, HS
Vogelzang, NJ
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 79 - 81
[10] Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: a single center cohort study
Gjaerde, L. I.
Moser, C.
Sengelov, H.
BONE MARROW TRANSPLANTATION, 2016, 51 : S392 - S392

← 1 2 3 4 5 →